US stock insider trading | Tectonic disclosed three insider trading transactions on March 5

K-LinePoet · 2026-04-10T14:09:48+00:00

Tectonic disclosed insider trading on March 5, 2026, with director REICIN ALISE purchasing 2,500 shares on March 4, and executive McNamara Peter selling 1,649 shares and 1,650 shares on March 3 and 4, respectively. The company focuses on developing biopharmaceuticals that modulate GPCR activity.

K-LinePoet

2026-04-10 14:09:48

Abstract generation in progress

On March 5, 2026, Tectonic (TECX) disclosed three insider trading transactions. Director REICIN ALISE purchased 2,500 shares on March 4, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 5, 2026	Director	REICIN ALISE	February 11, 2026	Buy	2,500	21.10	$52.8k
March 5, 2026	Executive	McNamara Peter	March 3, 2026	Sell	1,649	22.06	$36.4k
March 5, 2026	Executive	McNamara Peter	March 4, 2026	Sell	1,650	25.00	$41.3k
February 12, 2026	Executive	Schwabish Marc	February 10, 2026	Buy	4,500	2.38	$10.7k
February 11, 2026	Executive	Lochner Daniel	February 10, 2026	Buy	6,000	21.61	$129.7k
February 10, 2026	Director	REICIN ALISE	February 4, 2026	Sell	4,104	23.22	$95.3k
February 10, 2026	Executive	Ruddy Marcella K.	February 4, 2026	Sell	2,064	23.22	$47.9k
February 10, 2026	Executive	Schwabish Marc	February 4, 2026	Sell	1,619	23.22	$37.6k
February 10, 2026	Executive	Lochner Daniel	February 4, 2026	Sell	2,077	23.22	$48.2k
February 10, 2026	Executive	McNamara Peter	February 4, 2026	Sell	1,748	23.22	$40.6k

【Company Information】

Tectonic Therapeutic, Inc. is a company incorporated under Delaware law. It is a biotechnology company focused on discovering and developing therapeutic proteins and antibodies that modulate G protein-coupled receptor (“GPCR”) activity. Using its proprietary platform called GEODe (“GPCR Engineered for Optimal Discovery”), Tectonic focuses on developing biologic drugs to overcome existing challenges in GPCR-targeted drug discovery and to leverage the human body to alter disease progression. Tectonic concentrates on areas with significant unmet medical needs, often where treatment options are limited or nonexistent, as new drugs in these fields have the potential to improve patients’ quality of life.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes